Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕HDFC Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹127.6754₹15.6450
NAV date20 Nov 202620 Nov 2026
History—4.0 years
Expense ratio1.8%2.1%
StarsNot rated★★★★★
Growth Score—49.20

Returns

Nippon India Pharma FundHDFC Business Cycle Fund
1 month—+7.59%
3 months—+1.66%
6 months—+11.28%
YTD—+6.77%
1 year—+4.91%
3 years (CAGR)—+10.77%
5 years (CAGR)——
10 years (CAGR)——
Since launch—+11.89%

Risk

Nippon India Pharma FundHDFC Business Cycle Fund
Volatility—15.5%
Downside volatility—10.5%
Sharpe—0.28
Sortino—0.41
Calmar—0.56
Return / risk—0.70
Deepest fall—−19.40%
Days to recover—234
Below its high—+0.00%

Against benchmark

Nippon India Pharma FundHDFC Business Cycle Fund
Alpha—−0.70%
Beta—0.92
R²—90.6%
Up capture—92.4%
Down capture—94.3%
Tracking error—4.9%
Information ratio—−0.23
Treynor—0.04

Consistency

Nippon India Pharma FundHDFC Business Cycle Fund
Best 1-year—+38.26%
Middle 1-year—+5.55%
Worst 1-year—−7.13%
1-year periods with a loss—14.6%
Middle 3-year—+11.45%
Positive months—61.1%
Best day—+4.11%
Worst day—−6.25%
Worst 5% day—−1.53%
Positive days—54.3%
NAVs a year—247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR—+7.42%
1-year XIRR—+13.95%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth